News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
221,588 Results
Type
Article (5090)
Company Profile (23)
Press Release (216475)
Section
Business (82414)
Career Advice (461)
Deals (15063)
Drug Delivery (8)
Drug Development (19390)
Employer Resources (30)
FDA (3692)
Job Trends (3907)
News (120635)
Policy (7547)
Tag
Academia (310)
Alliances (14749)
Alzheimer's disease (225)
Approvals (3687)
Bankruptcy (94)
Best Places to Work (2838)
Biotechnology (25)
Breast cancer (19)
Cancer (198)
Career advice (392)
Cell therapy (44)
Clinical research (15830)
Collaboration (68)
Compensation (56)
COVID-19 (297)
C-suite (29)
Data (209)
Diagnostics (1986)
Earnings (39576)
Employer resources (31)
Events (36881)
Executive appointments (105)
FDA (3778)
Funding (68)
Gene therapy (24)
GLP-1 (94)
Government (408)
Healthcare (5032)
Infectious disease (306)
Inflammatory bowel disease (21)
Interviews (53)
IPO (7730)
Job creations (1122)
Job search strategy (361)
Layoffs (99)
Legal (2323)
Lung cancer (23)
Manufacturing (24)
Medical device (3818)
Medtech (3819)
Mergers & acquisitions (7347)
Metabolic disorders (54)
Neuroscience (263)
NextGen Class of 2024 (1685)
Non-profit (738)
Northern California (411)
Obesity (29)
Opinion (28)
People (24189)
Phase I (4725)
Phase II (6896)
Phase III (5457)
Pipeline (103)
Postmarket research (632)
Preclinical (1853)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (31)
Real estate (1869)
Regulatory (5009)
Research institute (309)
Resumes & cover letters (68)
Southern California (298)
Startups (1014)
United States (3450)
Vaccines (24)
Date
Today (64)
Last 7 days (246)
Last 30 days (812)
Last 365 days (11439)
2024 (9431)
2023 (13265)
2022 (18764)
2021 (19806)
2020 (18326)
2019 (13274)
2018 (10252)
2017 (10045)
2016 (9198)
2015 (12171)
2014 (9640)
2013 (7753)
2012 (8383)
2011 (8853)
2010 (8682)
Location
Africa (182)
Arizona (47)
Asia (11295)
Australia (1553)
California (818)
Canada (407)
China (23)
Colorado (30)
Connecticut (41)
Europe (23994)
Florida (105)
Georgia (17)
Idaho (23)
Illinois (71)
Indiana (33)
Japan (22)
Kansas (23)
Maine (32)
Maryland (110)
Massachusetts (717)
Michigan (55)
Minnesota (94)
Montana (16)
New Jersey (278)
New York (263)
North Carolina (222)
Northern California (411)
Ohio (31)
Pennsylvania (183)
South America (274)
Southern California (298)
Texas (92)
Utah (24)
Washington State (84)
221,588 Results for "neurogen corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurogene Announces Addition to Russell 3000® Index
Neurogene Inc. today announced that Neurogene will be added to the Russell 3000 ® Index, effective at the open of U.S. equity markets today, Monday, July 1, 2024.
July 1, 2024
·
5 min read
Pharm Country
Neurogene to Participate in Upcoming Conferences
Neurogene Inc. today announced that Company management will participate in the following conferences.
June 5, 2024
·
2 min read
Business
Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates
Neurogene Inc., a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, announced first quarter 2024 financial results and highlighted recent corporate updates.
May 10, 2024
·
10 min read
Pharm Country
Neurogene to Participate in Upcoming Investor Conferences
Neurogene Inc. today announced that Company management will participate in the following investor conferences.
February 29, 2024
·
1 min read
Drug Development
Neurogene Announces First Patient Dosed in High-Dose Cohort of NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
Neurogene Inc. (Nasdaq: NGNE) today announced that the first patient in Cohort 2 received high-dose NGN-401 gene therapy in the Phase 1/2 trial for female pediatric patients with Rett syndrome, and high-dose NGN-401 has been well-tolerated following dosing in May 2024.
June 18, 2024
·
7 min read
Pharm Country
Neurogene Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for START Pilot Program
Neurogene Inc. (NASDAQ: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that its NGN-401 gene therapy for Rett syndrome has been selected to participate in the U.S. Food and Drug Administration (FDA) Support for Clinical Trials Advancing Rare Disease Therapeutics (START) Pilot Program.
June 3, 2024
·
7 min read
News
Neurogene to Present Interim Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome
October 21, 2024
·
2 min read
Business
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced fourth quarter and full year 2023 financial results and highlighted recent corporate updates.
March 18, 2024
·
12 min read
Pharm Country
Neurogene Announces Business Update and 2024 Outlook
Neurogene Inc. (NASDAQ: NGNE) (“Neurogene” or “the Company”), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, announced today a business update and provided its outlook for 2024.
January 5, 2024
·
11 min read
Press Releases
Neurogene to Participate in BMO Genetic Medicines Summit
July 2, 2024
·
1 min read
1 of 22,159
Next